EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement

Michael H Woodworth iD, Roth E Conrad iD, Marina Haldopoulos iD, Stephanie M Pouch iD, Ahmed Babiker iD, Aneesh K Mehta iD, Kaitlin L Sitchenko iD, Charlotte H Wang iD, Amanda Strudwick iD, Jessica M Ingersoll, Cécile Philippe iD, Sarah Lohsen iD und 16 weitere

Science Translational Medicine · 2023-11 · 15 (720)

DOI: 10.1126/scitranslmed.abo2750 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Science Translational Medicine, 2023-11. Verfasst von Michael H Woodworth und 27 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation (FMT) can reduce MDRO colonization, but its mechanisms are poorly understood. We conducted a randomized, controlled trial of FMT for MDRO decolonization in renal transplant recipients called PREMIX (NCT02922816). Eleven participants were enrolled and randomized 1:1 to FMT or an observation period followed by delayed FMT if stool cultures were MDRO positive at day 36. Participants who were MDRO positive after one FMT were treated with a second FMT. At last visit, eight of nine patients who completed all treatments were MDRO culture negative. FMT-treated participants had longer time to recurrent MDRO infection versus PREMIX-eligible controls who were not treated with FMT. Key taxa ( Akkermansia muciniphila , Alistipes putredinis , Phocaeicola dorei , Phascolarctobacterium faecium , Alistipes species, Mesosutterella massiliensis , Barnesiella intestinihominis , and Faecalibacterium prausnitzii ) from the single feces donor used in the study that engrafted in recipients and metabolites such as short-chain fatty acids and bile acids in FMT-responding participants uncovered leads for rational microbiome therapeutic and diagnostic development. Metagenomic analyses revealed a previously unobserved mechanism of MDRO eradication by conspecific strain competition in an FMT-treated subset. Susceptible Enterobacterales strains that replaced baseline extended-spectrum β-lactamase–producing strains were not detectable in donor microbiota manufactured as FMT doses but in one case were detectable in the recipient before FMT. These data suggest that FMT may provide a path to exploit strain competition to reduce MDRO colonization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationGastrointestinal MicrobiomeHumansAnti-Bacterial AgentsDrug Resistance, BacterialFecesTreatment Outcome

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.
  • Ocean Science & Engineering, School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Emory Transplant Center, Atlanta, GA 30322, USA.
  • Emory College of Arts and Sciences, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Michael H Woodworth, Roth E Conrad, Marina Haldopoulos, Stephanie M Pouch, Ahmed Babiker, Aneesh K Mehta, Kaitlin L Sitchenko, Charlotte H Wang, Amanda Strudwick, Cécile Philippe, Sarah Lohsen, Kumru Kocaman, Janet K Hatt, Andrew S Neish, Geeta Karadkhele, Ken H Liu, Dean P Jones, C Christina Mehta, David S Weiss, Christian P Larsen, Konstantinos T Konstantinidis, Colleen S Kraft

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Woodworth, M. H., Conrad, R. E., Haldopoulos, M., Pouch, S. M., Babiker, A., Mehta, A. K., Sitchenko, K. L., Wang, C. H., Strudwick, A., Ingersoll, J. M., Philippe, C., Lohsen, S., Kocaman, K., Lindner, B. G., Hatt, J. K., Jones, R. M., Miller, C., Neish, A. S., Friedman-Moraco, R., …, & Kraft, C. S. (2023). Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Science Translational Medicine, 15(720). https://doi.org/10.1126/scitranslmed.abo2750

Vancouver

Woodworth MH, Conrad RE, Haldopoulos M, Pouch SM, Babiker A, Mehta AK, et al. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Science Translational Medicine. 2023;15(720). doi:10.1126/scitranslmed.abo2750

BibTeX
@article{Woodworth2023,
  author = {Woodworth, Michael H and Conrad, Roth E and Haldopoulos, Marina and Pouch, Stephanie M and Babiker, Ahmed and Mehta, Aneesh K and Sitchenko, Kaitlin L and Wang, Charlotte H and Strudwick, Amanda and Ingersoll, Jessica M and Philippe, Cécile and Lohsen, Sarah and Kocaman, Kumru and Lindner, Blake G and Hatt, Janet K and Jones, Rheinallt M and Miller, Candace and Neish, Andrew S and Friedman-Moraco, Rachel and Karadkhele, Geeta and Liu, Ken H and Jones, Dean P and Mehta, C Christina and Ziegler, Thomas R and Weiss, David S and Larsen, Christian P and Konstantinidis, Konstantinos T and Kraft, Colleen S},
  title = {Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {720},
  doi = {10.1126/scitranslmed.abo2750}
}
Kostenlos starten →